Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Accurate noninvasive diagnostic tests for endometriosis are still missing. This study evaluated the predictive value of the neuropeptide urocortin 1 (Ucn1) to detect pelvic endometriosis in symptomatic women. We enrolled prospectively 97 consecutive women submitted to gynecologic laparoscopy for chronic or acute pelvic pain, infertility or adnexal mass. Preoperative blood samples were assayed for Ucn1 using enzyme immunoassay. Patients with endometriosis had higher plasma Ucn1 levels compared to patients with no lesions (median 59 vs. 34 pg/ml, p < .01, Dunn's test). Elevated plasma Ucn1 levels were found among all endometriosis phenotypes (superficial peritoneal lesions, ovarian endometrioma, and deep infiltrating endometriosis, p < .05 vs. no lesions). Receiver operating characteristics curve analysis identified plasma Ucn1 > 46 pg/mL as the best cutoff point to detect endometriosis vs. no lesions, with 76% sensitivity and 88% specificity (area under the curve [AUC] 0.827, 95% confidence interval [CI] 0.695 - 0.959), but no cutoff could accurately distinguish endometriosis from other pathological conditions (AUC 0.593 [95% CI 0.474 - 0.711]). In women with chronic pelvic pain, infertility, or both symptoms, the probability of endometriosis (positive predictive value) increased consistently with the increase of plasma Ucn1 levels. The present findings suggest that high plasma Ucn1 levels increase the likelihood of endometriosis in symptomatic women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“elevated plasma Ucn1 levels are found among all endometriosis phenotypes.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [112]
In the citing paper
“no cutoff could accurately distinguish endometriosis from other pathological conditions, thus it is not useful [112].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [112]
In the citing paper
“the preoperative blood testing of Ucn among symptomatic women undergoing surgery for suspect of endometriosis showed that confirmed cases had higher plasma Ucn levels compared to patients with no lesions”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [112]
Citations
Cites
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Peripheral biomarkers of endometriosis: a systematic review
May, K. E., Conduit-Hulbert, S. A., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq009 · Cited by 418
Cloning and characterization of human urocortin.
Donaldson, C. J., Sutton, S. W., Perrin, M. H., Corrigan, A. Z., Lewis, K. A., Rivier, J. E., Vaughan, J. M., & Vale, W. W. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612563 · Cited by 372
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis
Reis, F. M., Petraglia, F., & Taylor, R. N. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt010 · Cited by 275 · cited 2×
“Although the pathogenesis of endometriosis is still disputed, the major hypothesis is that endometrial cells regurgitated into the peritoneum evoke an inflammatory response accompanied by neoangiogenesis, adhesions and peritoneal invasion [3].”
BackgroundSelf-citationPhysiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs
Fekete, É. M., & Zorrilla, E. P. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.002 · Cited by 243 · cited 1×
“In addition, other potential sources of Ucn1 include the central nervous system, immune tissues and cells such as lymphocytes and macrophages, connective tissues, grastrointestinal tract, kidneys and adrenal glands [20], which might be affected by the presence of endometriosis either directly (as in the case of intest…”
BackgroundUpdate on biomarkers for the detection of endometriosis
Fassbender, A., Burney, R. O., F. O, D., D’Hooghe, T., & Giudice, L. (2015) · BioMed Research International · doi:10.1155/2015/130854 · Cited by 195 · cited 1×
“However, because it is an invasive procedure, many patients are undiagnosed, delaying the treatment and contributing for disease progression [13,22].”
BackgroundAngiogenesis and Endometriosis
Rocha, A. L. L., Reis, F. M., & Taylor, R. N. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/859619 · Cited by 161 · cited 1×
“Endometriotic implants contribute to their own survival in the peritoneal surface promoting neovascularization through the release of proangiogenic factors [4].”
BackgroundSelf-citationDiagnostic Delay of Endometriosis in the Netherlands
Staal, A. H. J., van der Zanden, M., & Nap, A. W. (2016) · Gynecologic and Obstetric Investigation · doi:10.1159/000441911 · Cited by 156 · cited 1×
“However, because it is an invasive procedure, many patients are undiagnosed, delaying the treatment and contributing for disease progression [13,22].”
BackgroundRogers, P. A. W., D’Hooghe, T. M., Fazleabas, A., Giudice, L. C., Montgomery, G. W., Petraglia, F., & Taylor, R. N. (2013) · Reproductive Sciences · doi:10.1177/1933719113477495 · Cited by 154
Self-citationUrocortins in human reproduction
Florio, P., Vale, W., & Petraglia, F. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.026 · Cited by 82
Self-citation
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Self-citationIs Stress a Cause or a Consequence of Endometriosis?
dos Reis, F. M., Coutinho, L. M., Vannuccini, S., Luisi, S. V., & Petraglia, F. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00053-0 · Cited by 82
Self-citationNew biomarkers in endometriosis
(2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.12.002 · Cited by 72
Self-citationKimber-Trojnar, Ż., Pilszyk, A., Niebrzydowska-Tatus, M., Pilszyk, Z., Ruszała, M., & Leszczyńska‐Gorzelak, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132762 · Cited by 62
Pant, A., Moar, K., Arora, T. K., & Maurya, P. K. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117563 · Cited by 52
Metadata
- Authors
- Maia, L. M., Rocha, A. L., Del Puerto, H. L., Petraglia, F., & Reis, F. M.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Department of Pathology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil;
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Reis, Fernando M.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2017-09-19
- Volume
- 34
- Issue
- 3
- Pages
- 202-205
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2754753507
- Cited by
- 20
- References
- 24
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Funders
- FAPEMIG
- CNPq
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, urocortin 1, plasma biomarkers, preoperative diagnosis, chronic pelvic pain, infertility, endometrioma, deep infiltrating endometriosis, diagnostic accuracy, neuropeptides
- MeSH terms
- Adult, Cross-Sectional Studies, Endometriosis, Female, Humans, Middle Aged, Ovarian Diseases, Peritoneal Diseases, Prospective Studies, Biomarkers, Urocortins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. https://app.cochat.ai/papers/10.1080/09513590.2017.1380188
- The paper
- Maia, L. M., Rocha, A. L., Del Puerto, H. L., Petraglia, F., & Reis, F. M. (2018). Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2017.1380188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.